Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Epstein-Barr Virus Infections × avelumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 13 Urinary Bladder Neoplasms 12 Neoplasms 8 Carcinoma, Renal Cell 8 Carcinoma, Merkel Cell 8 Neoplasm Metastasis 7 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Ureteral Neoplasms 3 Skin Neoplasms 3 Prostatic Neoplasms 3 Colorectal Neoplasms 3 Urethral Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Turcot syndrome 1 Thymoma 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1

Interventions

Valganciclovir 3 Cisplatin 3 Vincristine 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Prednisone 2 Matrix-M 2 Gemcitabine 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 pomalidomide 1 dehydroftorafur 1 brincidofovir 1 Watchful Waiting 1 Valacyclovir 1 Tomography, X-Ray Computed 1 Tenofovir 1 Tegafur 1 Taxes 1 Platinum 1 Phantoms, Imaging 1 Paclitaxel 1 Nivolumab 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Lenalidomide 1 Interferons 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡